- My Forums
- Tiger Rant
- LSU Recruiting
- SEC Rant
- Saints Talk
- Pelicans Talk
- More Sports Board
- Winter Olympics
- Fantasy Sports
- Golf Board
- Soccer Board
- O-T Lounge
- Tech Board
- Home/Garden Board
- Outdoor Board
- Health/Fitness Board
- Movie/TV Board
- Book Board
- Music Board
- Political Talk
- Money Talk
- Fark Board
- Gaming Board
- Travel Board
- Food/Drink Board
- Ticket Exchange
- TD Help Board
Customize My Forums- View All Forums
- Show Left Links
- Topic Sort Options
- Trending Topics
- Recent Topics
- Active Topics
Started By
Message
re: AUPH - Aurinia Pharmaceuticals
Posted on 2/18/21 at 9:08 am to castorinho
Posted on 2/18/21 at 9:08 am to castorinho
It has not been i don't believe. But we gotta hear something I guess. Should at least see revenue moving up a little I'd think if we're in good position but maybe too soon
1
Posted on 2/19/21 at 9:23 pm to oklahogjr
Approval was 22 January ... Monday then?
This post was edited on 2/19/21 at 9:24 pm
Posted on 2/20/21 at 7:18 pm to bayoubengals88
quote:
Approval was 22 January ... Monday then?
Well shite that's gotta at least give us some signs
Posted on 2/20/21 at 7:38 pm to oklahogjr
Several presentations upcoming too. Maybe the Q&A will be interesting...
Posted on 2/24/21 at 3:38 pm to bayoubengals88
quote:
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.14) by 64.29 percent. This is a 82.76 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $50.00 million which beat the analyst consensus estimate of $40.00 thousand by 124.90K percent. This is a 172.31K percent increase over sales of $29.00 thousand the same period last year
Seems like all good news..
.. so I'll expect the price to drop 20% tomorrow
This post was edited on 2/24/21 at 3:39 pm
Posted on 2/24/21 at 3:44 pm to jmcwhrter
quote:
Seems like all good news..
.. so I'll expect the price to drop 20% tomorrow
Up $0.17 in after hours
This post was edited on 2/24/21 at 3:45 pm
Posted on 2/24/21 at 3:47 pm to Chucktown_Badger
price targets are much higher than the current price, i would think that's a really good sign to buy right now.
Posted on 2/24/21 at 3:52 pm to FMtTXtiger
- enough cash to make it through 2023 without any offerings
- working on expansion into Europe
- working on expansion into Europe
Posted on 2/24/21 at 3:55 pm to jmcwhrter
never fails.. this company gets some good news, and it gets released into "Chase Gamestop 2.0" tomorrow
cursed...
cursed...
Posted on 2/24/21 at 3:55 pm to jmcwhrter
this is exactly why my thesis that the stock market makes less sense than crypto is relevant
beats earnings, good revenue, expanding the pipeline and ...nothing
meanwhile, a bunch of autistic apes on wallstreet bets send GME to neptune
beats earnings, good revenue, expanding the pipeline and ...nothing
meanwhile, a bunch of autistic apes on wallstreet bets send GME to neptune
Posted on 2/24/21 at 4:00 pm to rocket31
.... are they reporting the $50 million they got up front from Otsuka as sales?
Posted on 2/24/21 at 4:50 pm to jmcwhrter
quote:
are they reporting the $50 million they got up front from Otsuka as sales?
It was list as revenue q4 2020.
Read from stock twits 75 patients so far.
Posted on 2/25/21 at 11:29 am to oklahogjr
I legitimately hate this stock. The price at which I will be willing to forgive it gets higher by the day.
Posted on 2/25/21 at 11:38 am to oklahogjr
quote:
Read from stock twits 75 patients so far.
As I've been saying for a while now, the most important factor is where this thing is falling on formulary. Not sure if anyone has looked into that. I haven't and I own the stock
Posted on 2/25/21 at 11:55 am to Chucktown_Badger
According to the earnings calls they are getting great responses from insurance companies. It looks like it will be covered by almost all insurances.
Posted on 2/25/21 at 11:59 am to Chucktown_Badger
quote:
Not sure if anyone has looked into that
not sure if anyone has any idea where to look into such things
Posted on 2/25/21 at 1:51 pm to redfishfan
quote:
It looks like it will be covered by almost all insurances.
Right, but how they're getting covered, and where they're getting covered is what matters. And it will vary by company. This is what I'm talking about, and without significant progress on the access side, this thing will go nowhere.
quote:
I think you covered it perfectly. I think the only other thing that we're going to be watching very closely is prepare to develop LUPKYNIS-specific coverage policies. Right now, we only -- we have one payer that's developed a LUPKYNIS-specific coverage policy, Blue Cross Blue Shield of North Carolina. And I'm sure many others will follow in the next months.
Posted on 2/25/21 at 9:44 pm to Chucktown_Badger
quote:
Right, but how they're getting covered, and where they're getting covered is what matters. And it will vary by company. This is what I'm talking about, and without significant progress on the access side, this thing will go nowhere.
Trying to understand what this means from a milestone perspective obviously the market wasn't excited about anything today but that doesn't necessarily mean value isn't there.
So what kinda timeline do these drugs usually take to get these plans rolled out? Do you think with only 1 so far that puts them ahead or behind the 8 ball?
This is my first biotech I'm following intensely so trying to learn sad much as possible about the things to watch
Posted on 2/26/21 at 12:04 pm to oklahogjr
well started a second position here. $14.50 avg 
Posted on 2/26/21 at 12:22 pm to oklahogjr
quote:
So what kinda timeline do these drugs usually take to get these plans rolled out? Do you think with only 1 so far that puts them ahead or behind the 8 ball?
All pharma companies have full divisions whose sole job it is to get better positioning on formulary (insurance). It can often times be a drawn out process with lots of negotiations around the financials and rebates, PE (pharmacoeconomic) data and discussions, etc. As they line up wins (eg first line, preferred status, etc) with the major insurers we should see the needle start to move, but I can't say how long it will take, if it happens at all.
Basically they need to provide the data to the insurers that convinces them that paying for this drug will save them money in the long run versus paying for a different drug at the same line of therapy.
This post was edited on 2/26/21 at 12:23 pm
Page 69 of 167
Popular
Back to top
Follow TigerDroppings for LSU Football News